Toggle Site Contrast

2021 Medicine Disclosure Log

Covid Deaths March 2020 to December 2020 FOI 339,

Biologic Products for Severe Asthma Treatment FOI 357,

DXA or DEXA Bone Densitometry FOI 359,

Bevacizumab Treatment – FOI 371,

Drugs Used in Treatment of Rheumatology Patients – FOI 378,

Neurology Patients Treatment – FOI 390,

Drugs Used in Treatment for Dermatology and Gastroenterology Patients – FOI 395,

Cancer Support Services – FOI 398,

Urothelial Cancer Patients Treatment – FOI 1055,

Contacting patients for appointments and surgery

We have begun sending text messages and letters out to patients on our waiting lists.

Please be reassured that these messages are legitimate. It is important that you respond to these messages as quickly as possible after receiving them. If you need to get in contact with us, please use either the email address or telephone number provided on your original letter.

You may receive a message:

To ask if you still require treatment and would like to remain on our waiting list.

or,

You have been waiting over 40 weeks for an appointment or procedure and would like to request to move to another hospital, who may be able to see you sooner.